Caris Life Sciences, Inc. logo CAI - Caris Life Sciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 6
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $28.60 DETAILS
HIGH: $38.00
LOW: $21.00
MEDIAN: $30.00
CONSENSUS: $28.60
UPSIDE: 83.92%
Metric 2025 2024 2023 2022 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Revenue
Revenue 812.0 412.3 306.1 258.5 294.0 416.5 432.1 348.4 294.4 249.7 227.6 212.4 173.9 125.7 77.9 65.3 83.1 64.9 18.6 61.6 66.7 48.1
Cost of Revenue 272.9 233.5 216.8 178.5 109.9 216.0 218.5 179.1 156.9 123.8 78.0 67.1 48.4 5.5 6.2 8.7 4.9 4.0 1.2 0 0 0
Gross Profit 539.2 178.8 89.3 80.0 184.2 200.5 213.6 169.3 137.5 125.9 149.6 145.3 125.6 120.2 71.7 56.5 78.3 60.8 17.4 61.6 66.7 48.1
Operating Expenses
R&D Expenses 45.3 113.9 116.9 101.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SG&A Expenses 392.5 321.9 291.5 294.5 27.3 52.7 50.3 42.7 35.7 27.6 0 19.3 0 0 0 0 0 0 0 0 0 0
Other Expenses 56.3 0.1 0.5 0 17.8 17.5 14.5 20.9 35.9 30.2 52.6 24.6 35.0 55.9 34.8 33.7 34.0 20.9 5.4 37.4 43.7 44.4
Operating Expenses 494.1 435.9 408.9 395.8 45.1 70.2 64.8 63.6 71.5 57.8 52.6 43.9 35.0 55.9 34.8 33.7 34.0 20.9 5.4 37.4 43.7 44.4
Operating Income
Operating Income 45.1 (257.1) (319.6) (315.8) 139.1 130.3 148.8 105.7 66.0 68.1 97.0 101.4 90.6 64.3 37.0 22.8 44.3 39.9 12.0 24.1 23.0 3.7
Interest Expense 56.9 50.0 31.6 26.7 61.6 79.2 78.3 53.1 42.8 36.0 35.2 36.0 28.8 16.1 5.3 4.3 9.3 10.4 3.7 7.8 7.7 7.4
Interest Income 16.5 7.1 11.3 0.9 0 0 0 0 0 0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0 0
Profitability
EBITDA 11.4 (183.0) (260.8) (245.9) 254.5 248.3 283.3 223.5 159.3 181.4 181.5 175.4 151.8 112.7 59.6 40.7 11.5 51.5 14.9 39.0 38.6 19.1
EBIT (11.2) (231.9) (309.8) (294.1) 143.8 134.4 159.8 110.3 52.6 67.3 102.8 107.6 102.9 78.0 37.0 21.8 (6.1) 40.7 12.1 24.2 23.0 3.7
Income Before Tax (68.1) (281.9) (341.4) (320.8) 29.5 55.2 81.5 57.2 9.9 31.2 67.6 71.6 74.1 61.9 31.8 17.5 (15.4) 30.3 8.4 16.4 15.4 (3.7)
Income Tax Expense 469.9 0 0 0 1.8 4.2 2.9 (14.9) 3.8 4.3 7.2 7.1 9.8 11.1 3.6 3.9 11.5 11.1 3.1 6.4 6.1 (1.0)
Net Income (538.0) (281.9) (341.4) (320.8) 27.7 31.0 78.6 72.1 6.0 26.8 60.3 63.9 63.5 50.2 28.4 13.6 (27.0) 19.2 5.2 10.0 9.2 (2.6)
Per Share Data
EPS (Basic) -1.90 -2.70 -1.82 -1.57 1.55 1.72 3.97 3.74 0.31 1.29 2.91 2.89 3.26 2.60 1.58 0.76 -1.55 1.31 0.25 0.47 0.44 -0.13
EPS (Diluted) -1.90 -2.70 -1.82 -1.57 1.55 1.72 3.97 3.68 0.31 1.28 2.85 2.82 3.18 2.55 1.56 0.76 -1.55 1.15 0.25 0.47 0.44 -0.13
Shares Outstanding 1,672.1 254.7 254.7 254.8 17.9 18.0 19.8 19.3 19.3 20.8 20.7 22.2 19.5 19.3 18.0 17.9 17.4 14.7 21.2 21.2 21.2 21.2
Metric 2025 2024 2023 2022 2020 2019 2018 2017 2016 2015 2009 2008 2004 2003
Current Assets
Cash & Cash Equivalents 797.8 64.0 56.4 107.2 53.5 46.5 45.3 35.4 46.1 52.6 14.5 28.5 5.5 3.3
Short-Term Investments 2.3 2.2 65.2 302.4 79.0 0 76.0 30.1 20.0 21.2 6.8 0 0 0
Net Receivables 112.1 88.2 55.3 40.2 144.3 159.7 171.9 100.7 83.7 76.4 33.4 40.9 0 0
Inventory 0 39.6 49.0 47.0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 85.6 8.2 5.0 5.9 (62.2) 293.0 (73.2) (25.8) (14.6) (6.0) 8.7 11.5 0 0
Total Current Assets 997.8 215.7 242.6 516.0 214.7 499.1 220.0 140.3 135.2 144.1 63.4 81.0 5.5 3.3
Non-Current Assets
Property, Plant & Equipment 63.2 102.8 147.5 138.0 1,781.3 1,820.7 2,266.2 2,005.3 1,807.6 1,748.9 299.8 311.0 0 0
Goodwill 19.3 19.3 19.3 19.3 0 15.8 15.8 15.8 15.8 2.9 0 0 0 0
Intangible Assets 0 0 0 0 0 4.1 5.7 7.7 9.7 1.2 5.1 6.6 0 0
Long-Term Investments 0 0 0 0 0 495.5 473.8 246.4 80.6 82.2 5.8 14.0 0 0
Other Non-Current Assets 45.3 5.9 3.4 44.0 616.6 66.5 31.1 14.8 7.2 7.2 0 0 0 0
Total Non-Current Assets 127.9 128.0 170.3 201.4 2,398.0 2,402.6 2,792.6 2,290.1 1,920.8 1,842.4 310.7 331.6 0 0
Total Assets 1,125.7 343.7 412.9 717.4 2,612.6 2,901.8 3,012.6 2,430.4 2,055.9 1,986.5 374.1 412.6 182.0 193.1
Current Liabilities
Account Payables 39.2 27.8 26.7 27.3 3.7 7.3 7.4 7.8 13.8 12.0 8.0 4.7 0 0
Short-Term Debt 0.2 60 0.2 52.8 183.4 218.1 311.4 132.0 95.5 172.4 4.6 4.5 0 0
Deferred Revenue 0 7.5 5.7 1.4 3.0 6.4 7.6 7.8 10.6 12.0 4.2 4.5 0 0
Other Current Liabilities 87.8 30.7 22.1 22.6 130.1 55.6 99.2 112.2 44.1 21.5 21.6 31.5 0 0
Total Current Liabilities 127.1 165.4 95.1 136.9 320.2 287.4 425.5 259.9 164.0 217.9 38.5 45.2 0 0
Non-Current Liabilities
Long-Term Debt 378.8 319.2 166.1 169.6 1,562.3 1,880.1 1,847.6 1,570.8 1,380.5 1,259.2 163.6 208.2 98.7 120.7
Deferred Tax Liabilities 0 0 0 0 24.4 35.4 38.3 35.9 51.8 48.2 26.6 25.3 0 0
Other Non-Current Liabilities 42.4 2,319.1 2,252.2 2,068.8 3.4 5.6 0 0 2.1 0 16.3 20.1 0 0
Total Non-Current Liabilities 421.2 2,677.1 2,462.7 2,282.6 1,590.1 1,921.1 1,886.0 1,606.6 1,434.4 1,307.4 206.5 253.6 98.7 120.7
Total Liabilities 548.4 2,842.6 2,557.8 2,419.5 1,910.4 2,208.5 2,311.5 1,866.6 1,598.4 1,525.3 245.0 298.8 158.1 177.9
Stockholders' Equity
Common Stock 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
Retained Earnings (2,548.7) (2,472.3) (2,119.2) (1,678.7) 503.3 493.3 471.1 397.6 324.6 319.7 26.7 13.1 0 0
Accumulated Other Comprehensive Income 0.9 0.2 0.2 1.7 (5.7) (6.6) (6.5) (6.1) (8.1) (7.9) (1.2) (2.0) 0 0
Total Stockholders' Equity 577.3 (2,498.8) (2,144.9) (1,702.1) 702.2 693.2 701.1 563.8 457.5 460.3 129.1 113.8 23.8 15.2
Total Liabilities & Equity 1,125.7 343.7 412.9 717.4 2,612.6 2,901.8 3,012.6 2,430.4 2,055.9 1,985.6 374.1 412.6 182.0 193.1
Debt Metrics
Total Debt 379.0 424.3 217.3 270.9 1,745.7 2,098.2 2,159.0 1,702.8 1,476.0 1,431.6 168.3 212.7 98.7 120.7
Net Debt (418.8) 360.3 160.9 163.7 1,692.2 2,051.8 2,113.7 1,667.4 1,429.9 1,379.1 153.8 184.2 93.1 117.3
Metric 2025 2024 2023 2022 2020 2019 2018 2017 2016 2015 2005 2004 2003
Operating Activities
Net Income (68.1) (281.9) (341.4) (320.8) 27.7 31.0 78.6 72.1 6.0 26.8 10.0 9.2 (2.6)
Depreciation & Amortization 22.6 48.9 49.0 48.3 110.7 113.9 123.5 113.3 106.7 114.2 14.9 15.5 15.4
Stock-Based Compensation 70.0 18.6 15.2 22.9 1.8 2.8 2.9 2.1 1.7 1.9 0 0 0
Change in Working Capital (33.1) (29.1) (7.1) (22.3) (317.3) 417.2 (85.9) (90.7) 44.9 30.6 (3.6) 0 0
Other Non-Cash Items 91.7 (1.8) 8.2 (13.8) 452.8 (314.7) 58.3 73.5 (31.2) (31.2) 1.8 (24.8) (12.7)
Operating Cash Flow 83.2 (245.2) (276.1) (285.7) 277.0 254.0 179.8 155.2 129.3 147.4 29.4 0 0
Investing Activities
Capital Expenditure (16.3) (8.4) (22.3) (42.3) (219.4) (319.1) (812.8) (502.2) (251.2) (389.4) (0.3) (125.7) (60.7)
Acquisitions 0 0 0 0 0 0 0 0 (16.1) (4.1) 0 0 0
Purchases of Investments 0 0 (63.4) (378.4) 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 61.4 300.5 137.6 0 0 43.4 24.1 19.6 22.1 0 0 0
Other Investing Activities 0 0 0 0 185.5 47.3 106.1 66.4 66.1 66.2 (7.9) 125.7 60.7
Investing Cash Flow (16.3) 52.9 214.8 (283.0) (34.0) (271.9) (663.3) (411.8) (181.6) (305.2) (8.2) (125.7) (60.7)
Financing Activities
Net Debt Issuance 16.0 199.8 10.6 (1.0) 0 0 0 0 0 0 0 0 0
Stock Repurchased (0.1) 0 0 0 (7.9) (34.1) (40.9) 0 (9.2) (13.0) 0 0 0
Dividends Paid 0 0 0 0 (17.7) (8.8) (3.3) 0 0 0 0 0 0
Other Financing Activities (18.6) 0.5 (0.4) 11.4 (232.2) (99.7) 515.6 245.6 46.6 156.5 (19.0) 0 0
Financing Cash Flow 665.0 200.3 10.1 10.4 (249.9) (108.5) 512.4 245.6 46.6 156.5 (19.0) 0 0
Cash Position
Net Change in Cash 732.0 8.0 (51.1) (558.2) (6.7) (2.7) 28.8 (10.7) (6.4) (1.3) 2.0 (125.7) (60.7)
Cash at Beginning 68.0 60.0 111.1 669.4 73.2 76.0 47.2 46.1 52.6 53.8 5.5 0 0
Cash at End 800.0 68.0 60.0 111.1 66.5 73.2 76.0 35.4 46.1 52.6 7.6 (125.7) (60.7)
Free Cash Flow 66.9 (253.6) (298.4) (328.0) 57.6 (65.1) (633.1) (347.0) (122.0) (242.0) 29.1 (125.7) (60.7)
Key Metrics 2025 2024 2023 2022 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Income Statement
Revenue 812.0 412.3 306.1 258.5 294.0 416.5 432.1 348.4 294.4 249.7 227.6 212.4 173.9 125.7 77.9 65.3 83.1 64.9 18.6 61.6 66.7 48.1
Gross Profit 539.2 178.8 89.3 80.0 184.2 200.5 213.6 169.3 137.5 125.9 149.6 145.3 125.6 120.2 71.7 56.5 78.3 60.8 17.4 61.6 66.7 48.1
Operating Income 45.1 (257.1) (319.6) (315.8) 139.1 130.3 148.8 105.7 66.0 68.1 97.0 101.4 90.6 64.3 37.0 22.8 44.3 39.9 12.0 24.1 23.0 3.7
Net Income (538.0) (281.9) (341.4) (320.8) 27.7 31.0 78.6 72.1 6.0 26.8 60.3 63.9 63.5 50.2 28.4 13.6 (27.0) 19.2 5.2 10.0 9.2 (2.6)
EPS (Diluted) -1.90 -2.70 -1.82 -1.57 1.55 1.72 3.97 3.68 0.31 1.28 2.85 2.82 3.18 2.55 1.56 0.76 -1.55 1.15 0.25 0.47 0.44 -0.13
Balance Sheet
Cash & Equivalents 797.8 64.0 56.4 107.2 53.5 46.5 45.3 35.4 46.1 52.6 14.5 28.5 5.5 3.3
Total Assets 1,125.7 343.7 412.9 717.4 2,612.6 2,901.8 3,012.6 2,430.4 2,055.9 1,986.5 374.1 412.6 182.0 193.1
Total Debt 379.0 424.3 217.3 270.9 1,745.7 2,098.2 2,159.0 1,702.8 1,476.0 1,431.6 168.3 212.7 98.7 120.7
Stockholders' Equity 577.3 (2,498.8) (2,144.9) (1,702.1) 702.2 693.2 701.1 563.8 457.5 460.3 129.1 113.8 23.8 15.2
Cash Flow
Operating Cash Flow 83.2 (245.2) (276.1) (285.7) 277.0 254.0 179.8 155.2 129.3 147.4 29.4 0 0
Capital Expenditure (16.3) (8.4) (22.3) (42.3) (219.4) (319.1) (812.8) (502.2) (251.2) (389.4) (0.3) (125.7) (60.7)
Free Cash Flow 66.9 (253.6) (298.4) (328.0) 57.6 (65.1) (633.1) (347.0) (122.0) (242.0) 29.1 (125.7) (60.7)